Lazard Healthcare Acquisition I informed the SEC that it will withdraw an offering of 25 million units registered in March 2021.
The SPAC in its S-1 filing noted plans to target the biotechnology, medical technology, life science tools and diagnostics, healthcare information technology and technology-enabled healthcare services subsectors.
Lazard Healthcare is led by Executive Chairman and Director Alexander Stern, president of Lazard Ltd and Lazard Group since June 2019 and managing director of Lazard since 2002. Read more.
